This is an aggregated industry headline. Read the full story at Drug Channels →
Direct-to-Patient: Transforming the Manufacturer Access Model
Today's guest post comes from Chip Parkinson, CEO at Gifthealth. Chip discusses how Direct-to-Patient (DTP) models can transform the manufacturer access model for prescription therapies. He argues that a tech-plus-touch, end-to-end approach can improve patient access, protect manufacturer economics,
By Drug Channels
· Jul 24, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
An FDA advisory committee has recommended that four peptide drugs that were previously restricted because of p…
The WeekFierceBiotech ↗
Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once t…
The WeekSTAT News ↗
The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of…